(NASDAQ: MRUS) Merus Nv's forecast annual revenue growth rate of 13.89% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.97%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.99%.
Merus Nv's revenue in 2025 is $69,385,000.On average, 6 Wall Street analysts forecast MRUS's revenue for 2025 to be $4,163,141,967, with the lowest MRUS revenue forecast at $3,880,042,565, and the highest MRUS revenue forecast at $4,640,167,863. On average, 6 Wall Street analysts forecast MRUS's revenue for 2026 to be $3,016,903,272, with the lowest MRUS revenue forecast at $196,649,331, and the highest MRUS revenue forecast at $5,250,537,132.
In 2027, MRUS is forecast to generate $9,165,220,234 in revenue, with the lowest revenue forecast at $1,685,889,840 and the highest revenue forecast at $15,408,231,412.